---
schema_version: "secwatch.filing_event.v1"
accession: "0001816590-25-000008"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:28:44.510661+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Compass Pathways prices $150M offering of ADS and warrants to fund Phase 3 depression/PTSD trials

## Summary
- Offering of 24.0M ADS and 11.0M pre-funded warrants plus accompanying ADS warrants at $4.275/unit (ADS warrant strike $5.796).
- Gross proceeds ~$150M; up to ~$353M if ADS warrants fully exercised; led by Deep Track Capital.
- Net proceeds fund ongoing COMP005/COMP006 Phase 3 depression trials (data Q2 2025, H2 2026) and accelerate PTSD program.
- Company terminates ATM sales agreement (up to $93.5M capacity) effective January 9, 2025.
- Offering expected to close January 13, 2025; 60-day lock-up for officers/directors.

## SEC filing metadata
- accession: 0001816590-25-000008
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000181659025000008/0001816590-25-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000181659025000008/cmps-20250109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001816590-25-000008
- JSON: https://secwatch.observer/filing/0001816590-25-000008.json
- Plain text: https://secwatch.observer/filing/0001816590-25-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.